Cardiovascular and renal protective effects of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation.
Seong Huan ChoiMina KimHoseob KimDae Hyeok KimYong Soo BaekPublished in: PloS one (2022)
NOACs were associated with a significantly lower risk of adverse CV and renovascular outcomes than warfarin in patients with AF.